Geoff Symonds is Head of Scientific Affairs and Collaborations at Callimune Inc. and focuses on the future applications of the therapy and technologies that can partner with the constructs being developed. Before joining Calimmune Geoff worked for 16 years at Johnson & Johnson and was Senior Research Director and Global Product Leader, HIV Gene Therapy working on basic and clinical research in the area of cell-delivered gene therapy for HIV. Dr Symonds has published widely and has served on and continues to serve on various government and institutional committees.